These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23606545)

  • 1. Oil-filled lipid nanoparticles containing 2'-(2-bromohexadecanoyl)-docetaxel for the treatment of breast cancer.
    Feng L; Benhabbour SR; Mumper RJ
    Adv Healthc Mater; 2013 Nov; 2(11):1451-7. PubMed ID: 23606545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and optimization of oil-filled lipid nanoparticles containing docetaxel conjugates designed to control the drug release rate in vitro and in vivo.
    Feng L; Wu H; Ma P; Mumper RJ; Benhabbour SR
    Int J Nanomedicine; 2011; 6():2545-56. PubMed ID: 22072889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a novel orthotopic non-small cell lung cancer model and therapeutic benefit of 2'-(2-bromohexadecanoyl)-docetaxel conjugate nanoparticles.
    Peng L; Feng L; Yuan H; Benhabbour SR; Mumper RJ
    Nanomedicine; 2014 Oct; 10(7):1497-506. PubMed ID: 24709328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2'-(2-bromohexadecanoyl)-paclitaxel conjugate nanoparticles for the treatment of non-small cell lung cancer in an orthotopic xenograft mouse model.
    Peng L; Schorzman AN; Ma P; Madden AJ; Zamboni WC; Benhabbour SR; Mumper RJ
    Int J Nanomedicine; 2014; 9():3601-10. PubMed ID: 25114529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Antitumor Efficacy and Reduced Toxicity of Docetaxel Loaded Estradiol Functionalized Stealth Polymeric Nanoparticles.
    Jain S; Spandana G; Agrawal AK; Kushwah V; Thanki K
    Mol Pharm; 2015 Nov; 12(11):3871-84. PubMed ID: 26375023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of lipid emulsions of docetaxel-linoleic acid conjugate in breast cancer.
    Zhang T; Li M; Yang R; Zhang D; Guan J; Yu J; Yang B; Zhang H; Zhang S; Liu D; Wang Y
    Int J Pharm; 2018 Jul; 546(1-2):61-69. PubMed ID: 29763687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells.
    Tavassolian F; Kamalinia G; Rouhani H; Amini M; Ostad SN; Khoshayand MR; Atyabi F; Tehrani MR; Dinarvand R
    Int J Pharm; 2014 Jun; 467(1-2):123-38. PubMed ID: 24680951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manganese oxide and docetaxel co-loaded fluorescent polymer nanoparticles for dual modal imaging and chemotherapy of breast cancer.
    Abbasi AZ; Prasad P; Cai P; He C; Foltz WD; Amini MA; Gordijo CR; Rauth AM; Wu XY
    J Control Release; 2015 Jul; 209():186-96. PubMed ID: 25908171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of docetaxel-loaded polymeric nanoparticles fabricated by Shirasu porous glass membrane-emulsification technique.
    Yu Y; Tan S; Zhao S; Zhuang X; Song Q; Wang Y; Zhou Q; Zhang Z
    Int J Nanomedicine; 2013; 8():2641-52. PubMed ID: 23935362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved Antitumor Efficacy of a Dextran-based Docetaxel-coupled Conjugate against Triple-Negative Breast Cancer.
    Lv H; Jia W; Dong P; Liu J; Wang S; Li X; Hu J; Zhao L; Shi Y
    Curr Drug Deliv; 2024; 21(5):775-784. PubMed ID: 37349996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-Ligand Modified Polymer-Lipid Hybrid Nanoparticles for Docetaxel Targeting Delivery to Her2/neu Overexpressed Human Breast Cancer Cells.
    Yang Z; Tang W; Luo X; Zhang X; Zhang C; Li H; Gao D; Luo H; Jiang Q; Liu J
    J Biomed Nanotechnol; 2015 Aug; 11(8):1401-17. PubMed ID: 26295141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-brain barrier-penetrating amphiphilic polymer nanoparticles deliver docetaxel for the treatment of brain metastases of triple negative breast cancer.
    He C; Cai P; Li J; Zhang T; Lin L; Abbasi AZ; Henderson JT; Rauth AM; Wu XY
    J Control Release; 2017 Jan; 246():98-109. PubMed ID: 28017889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicine: enhancement of chemotherapeutical efficacy of docetaxel by using a biodegradable nanoparticle formulation.
    Gan CW; Chien S; Feng SS
    Curr Pharm Des; 2010 Jul; 16(21):2308-20. PubMed ID: 20618152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer.
    Mi Y; Zhao J; Feng SS
    J Control Release; 2013 Aug; 169(3):185-92. PubMed ID: 23403395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical pharmacokinetic, biodistribution, and anti-cancer efficacy studies of a docetaxel-carboxymethylcellulose nanoparticle in mouse models.
    Ernsting MJ; Tang WL; MacCallum NW; Li SD
    Biomaterials; 2012 Feb; 33(5):1445-54. PubMed ID: 22079003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells.
    da Rocha MCO; da Silva PB; Radicchi MA; Andrade BYG; de Oliveira JV; Venus T; Merker C; Estrela-Lopis I; Longo JPF; Báo SN
    J Nanobiotechnology; 2020 Mar; 18(1):43. PubMed ID: 32164731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-delivering prodrug-nanoassemblies fabricated by disulfide bond bridged oleate prodrug of docetaxel for breast cancer therapy.
    Zhang S; Guan J; Sun M; Zhang D; Zhang H; Sun B; Guo W; Lin B; Wang Y; He Z; Luo C; Sun J
    Drug Deliv; 2017 Nov; 24(1):1460-1469. PubMed ID: 28950729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer.
    Wang Z; Zeng X; Ma Y; Liu J; Tang X; Gao Y; Liu K; Zhang J; Ming P; Huang L; Mei L
    J Biomed Nanotechnol; 2014 Aug; 10(8):1509-19. PubMed ID: 25016651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a weak-base docetaxel derivative that can be loaded into lipid nanoparticles.
    Zhigaltsev IV; Winters G; Srinivasulu M; Crawford J; Wong M; Amankwa L; Waterhouse D; Masin D; Webb M; Harasym N; Heller L; Bally MB; Ciufolini MA; Cullis PR; Maurer N
    J Control Release; 2010 Jun; 144(3):332-40. PubMed ID: 20202473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.